Total planned funding: $2,129,199,139
Clear active filters
NGO
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
South Africa | $354,473,135 |
Nigeria | $299,008,496 |
Kenya | $235,244,680 |
Uganda | $195,620,362 |
Tanzania | $195,607,055 |
Mozambique | $185,270,990 |
Zambia | $105,506,758 |
Zimbabwe | $78,315,788 |
Côte d'Ivoire | $68,471,277 |
Malawi | $65,981,173 |
Haiti | $58,926,405 |
Democratic Republic of the Congo | $37,364,889 |
Ethiopia | $27,690,566 |
Lesotho | $24,893,300 |
Central America Region | $18,679,124 |
Vietnam | $18,327,508 |
Botswana | $17,899,859 |
Eswatini | $14,556,480 |
Namibia | $13,566,773 |
India | $12,984,106 |
Burundi | $11,328,984 |
Cameroon | $10,135,026 |
Ukraine | $9,271,998 |
Angola | $8,969,328 |
Rwanda | $8,792,936 |
Cambodia | $8,058,855 |
Dominican Republic | $7,991,377 |
Papua New Guinea | $7,403,865 |
South Sudan | $7,033,406 |
Caribbean Region | $6,925,306 |
Indonesia | $5,994,394 |
Asia Regional Program | $4,327,521 |
Central Asia Region | $2,410,000 |
Burma | $2,000,000 |
Guyana | $144,700 |
Ghana | $22,719 |
Organizational Types
NGO | $2,129,199,139 |
Program Areas
Treatment | $817,787,779 |
Care | $585,928,670 |
Prevention | $397,934,989 |
Governance and Systems | $182,943,073 |
Testing | $154,249,874 |
Budget Codes
HTXS: Treatment: Adult Treatment | $708,107,792 |
HBHC: Care: Adult Care and Support | $242,257,395 |
HKID: Care: Orphans and Vulnerable Children | $197,018,755 |
HVCT: Testing: HIV Testing and Counseling | $154,249,874 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $134,560,297 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $117,666,687 |
HVOP: Sexual Prevention: Other Sexual Prevention | $115,446,812 |
HVTB: Care: TB/HIV | $98,292,004 |
PDTX: Treatment: Pediatric Treatment | $80,154,051 |
OHSS: Health Systems Strengthening | $69,306,554 |
HLAB: Laboratory Infrastructure | $65,686,619 |
PDCS: Care: Pediatric Care and Support | $48,360,516 |
HVSI: Strategic Information | $47,949,900 |
HTXD: Treatment: ARV Drugs | $29,525,936 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $13,315,605 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $7,865,364 |
HMBL: Biomedical Prevention: Blood Safety | $6,226,877 |
HMIN: Biomedical Prevention: Injection Safety | $2,853,347 |